Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

N6-methyladenine RNA Methylation Epigenetic Modification and Kidney Diseases

Kidney International Reports(2022)10.1016/j.ekir.2022.10.009Source: DataRank Database

N6-methyladenine RNA Methylation Epigenetic Modification and Kidney Diseases is a research paper published in Kidney International Reports (2022). On theSindex it has a DataRank of 0. It has been cited 25 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access25 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 1.81)OA: goldTopics (27)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Jeffrey B. Kopp ORCID,Hua Zhou ORCID,Junjun Luan

Live enrichment

PubMed:36644366 PMC:PMC9831943 OpenAlex:https://openalex.org/W4306393674

National Natural Science Foundation of China

Grant: 81770698

National Natural Science Foundation of China

Grant: 82100743

National Natural Science Foundation of China

Grant: 82170740

Liaoning Revitalization Talents Program

Grant: XLYC2002081

National Institute of Diabetes and Digestive and Kidney Diseases

National Institutes of Health

FWCI

1.81

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.ekir.2022.10.009

publisherhttps://doi.org/10.1016/j.ekir.2022.10.009

publisherhttps://api.elsevier.com/content/article/PII:S2468024922018216?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2468024922018216?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36644366

Fields of Study

RNA modifications and cancerCancer-related gene regulationEpigenetics and DNA Methylation

Keywords

RNA methylationEpigeneticsMethylationRNARNA splicingN6-MethyladenosineMedicineMessenger RNATranslation (biology)Computational biologyDNA methylationMethyltransferaseCancer researchGeneticsBioinformaticsBiologyGeneGene expressionReaderCkdAkiAkdWriterEraser

Sustainable Development Goals

SDG 0: Good health and well-being

N6-methyladenine RNA Methylation Epigenetic Modification and Kidney Diseases

FAIR Checklist

Authors (3)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)